Perbedaan Metro Healthcare Indonesia Tbk. dan Trimegah Karya Pratama Tbk.: Metro Healthcare Indonesia Tbk. diperdagangkan di Rp428 (kapitalisasi pasar 14,23 T, volume 24 jam 346,3 rb), sedangkan Trimegah Karya Pratama Tbk. diperdagangkan di Rp136 (kapitalisasi pasar 268,02 M, volume 24 jam 36,96 jt). Perbedaan utamanya: Metro Healthcare Indonesia Tbk. jauh lebih besar — sekitar 53,1× kapitalisasi pasar Trimegah Karya Pratama Tbk., dan Trimegah Karya Pratama Tbk. lebih aktif diperdagangkan (36,96 jt vs 346,3 rb). Mana yang lebih baik tergantung tujuan investasimu.
| CARE | UVCR | |
|---|---|---|
Kapitalisasi Pasar | 14,23 T | 268,02 M |
Volume | 346,3 rb | 36,96 jt |
Lot | 3,46 rb | 369,56 rb |
Perputaran | 147,93 jt | 5,02 M |
Harga Rata-rata | 427,18 | 135,74 |
Nilai Transaksi | 147,93 jt | 5,02 M |
Harga Ekuilibrium Indikatif | 428 | 136 |
Volume Ekuilibrium Indikatif | 10 | 2,08 rb |
Imbal hasil berjalan pada periode standar
Berita terbaru kedua aset
PT Metro Healthcare Indonesia Tbk (the “Company”) was established under the name PT Aruna Anjaya Perkasa, based on Notarial Deed No. 67 dated October 07, 2015 of Humberg Lie, S.H., S.E., M.Kn notary in Jakarta. The Company started its commercial operations in 2016 .
Selengkapnya di halaman CARE →PT Trimegah Karya Pratama Tbk (the Company) was established based on Notarial Deed No. 21 dated July 7, 2017 of Netty Maria Machdar, S.H. The Company started its commercial operations in 2018. The Company’s immediate parent company is PT Trimegah Sumber Mas, which was established and domiciled in Indonesia, while its ultimate Parent Company is PT Hutama Mulia Rajawali, which was established and domiciled in Indonesia.
Selengkapnya di halaman UVCR →